Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: A meta-analysis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Fu, Jian Fei ^a,b,c   Chen, Hai Long ^a,b   Yang, Jiao ^a,b   Yi, Cheng Hao ^a,b   Zheng, Shu ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ACCURACY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; FALSE NEGATIVE RESULT; FEASIBILITY STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NODE POSITIVE BREAST CANCER; PATIENT SELECTION; SENTINEL LYMPH NODE BIOPSY; STAINING; SYSTEMATIC REVIEW; ADJUVANT THERAPY; AXILLA; BREAST NEOPLASMS; FEMALE; LYMPH NODE; LYMPH NODE DISSECTION; META ANALYSIS; PATHOLOGY; PROCEDURES;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOADJUVANT THERAPY; SENTINEL LYMPH NODE BIOPSY;

EID: 84907502475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105316     Document Type: Article

References (32)

1. Cure H, Amat S, Penault-Llorca F, le Bouedec G, Ferriere JP, et al. (2002) Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy. Breast Cancer Res Treat 76: 37-45.
2. Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, et al. (2002) Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with Tl to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20: 1304 -1310.
3. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187.
4. Hack TF, Cohen L, Katz J, Robson LS, Goss P (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17: 143-149.
5. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, et al. (1998) The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 339: 941-946.
6. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, et al. (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349: 1864-1867.
7. Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, et al. (2012) Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg 256: 428-436.
8. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252: 426-432; discussion 432-423.
9. Bear HD, Anderson S, Smith RE, Geyer CE Jr, Mamounas EP, et al. (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24: 2019-2027.
10. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, et al. (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15: 2483-2493.
11. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Decks JJ, et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155: 529-536.
12. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, et al. (2012) The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19: 3177-3184.
13. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, et al. (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310: 1455-1461.
14. Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, et al. (2010) Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 116: 2878-2883.
15. Canavese G, Dozin B, Vecchio C, Tomei D, Villa G, et al. (2011) Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes. Eur J Surg Oncol 37: 688-694.
16. Classe JM, Bordes V, Campion L, Mignotte H, Dravet F, et al. (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 27: 726-732.
17. Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, et al. (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14: 609-618.
18. Lee S, Kim EY, Kang SH, Kim SW, Kim SK, et al. (2007) Sentinel node identification rate, but not accuracy, is significantiy decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 102: 283-288.
19. Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, et al. (2007) Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 14: 2946-2952.
20. Ozmen V, Unal ES, Muslumanoglu ME, Igci A, Canbay E, et al. (2010) Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol 36: 23 -29.
21. Park S, Park JM, Cho JH, Park HS, Kim SI, et al. (2013) Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Ann Surg Oncol 20: 2858-2865.
22. Rebollo-Aguirre AC, Gallego-Peinado M, Menjon-Beltran S, Garcia-Garcia J, Pastor-Pons E, et al. (2012) Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy. Rev Esp Med Nucl Imagen Mol 31: 117-123.
23. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, et al. (2007) Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109: 1255-1263.
24. Takei H, Yoshida T, Kurosumi M, Inoue K, Matsumoto H, et al. (2013) Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation. Int J Clin Oncol 18: 547-553.
25. Thomas S, Prakash A, Goyal V, Popli MB, Agarwal S, et al. (2011) Evaluation of sentinel node biopsy in locally advanced breast cancer patients who become clinically node-negative after neoadjuvant chemotherapy: a preliminary study. Int J Breast Cancer 2011: 870263.
26. Yagata H, Yamauchi H, Tsugawa K, Hayashi N, Yoshida A, et al. (2013) Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Clin Breast Cancer 13: 471 -477.
27. van Deurzen CH, Vriens BE, Tjan-Heijnen VC, van der Wall E, Albregts M, et al. (2009) Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 45: 3124-3130.
28. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, et al. (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93: 539-546.
29. Tan VK, Goh BK, Fook-Chong S, Khin LW, Wong WK, et al. (2011) The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer-a systematic review and meta-analysis. J Surg Oncol 104: 97-103.
30. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC (1999) Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84: 138-142.
31. Fraile M, Rull M, Julian FJ, Fuste F, Barnadas A, et al. (2000) Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 11: 701-705.
32. Kenne JD, Jelfe DB, Schootman M, Hoffman A, Gillanders WE, et al. (2010) Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg 199: 477M84.